Sandeep K. Talapatra
29/39 Brunswick Square
London, ENG WC1N1AX, United Kingdom
London, ENG WC1N1AX, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Phenyl Bis-Sulfonamide Keap1-Nrf2 Protein-Protein Interaction Inhibitors with an Alternative Binding Mode.
Journal: Journal of medicinal chemistry
Published: May 13, 2022
Is the Fate of Clinical Candidate Arry-520 Already Sealed? Predicting Resistance in Eg5-Inhibitor Complexes.
Journal: Molecular cancer therapeutics
Published: February 13, 2019
The depolymerase activity of MCAK shows a graded response to Aurora B kinase phosphorylation through allosteric regulation.
Journal: Journal of cell science
Published: December 04, 2018
Modified Peptide Inhibitors of the Keap1-Nrf2 Protein-Protein Interaction Incorporating Unnatural Amino Acids.
Journal: Chembiochem : a European journal of chemical biology
Published: May 29, 2018
Crystal structure of the Eg5 - K858 complex and implications for structure-based design of thiadiazole-containing inhibitors.
Journal: European journal of medicinal chemistry
Published: April 10, 2018
The structure of the binary methyltransferase-SAH complex from Zika virus reveals a novel conformation for the mechanism of mRNA capping.
Journal: Oncotarget
Published: July 05, 2017
Depsidones from Lichens as Natural Product Inhibitors of M-Phase Phosphoprotein 1, a Human Kinesin Required for Cytokinesis.
Journal: Journal of natural products
Published: June 15, 2016
New MKLP-2 inhibitors in the paprotrain series: Design, synthesis and biological evaluations.
Journal: Bioorganic & medicinal chemistry
Published: October 22, 2015
Mitotic kinesin Eg5 overcomes inhibition to the phase I/II clinical candidate SB743921 by an allosteric resistance mechanism.
Journal: Journal of medicinal chemistry
Published: July 24, 2013
Last Updated: 09/26/2026